PRISCILLA CARTER: Open Payments
NPI 1710664172 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 11 payments from 6 companies in 2025. Trend: 2023 $106 · 2024 $80 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $138 |
| Gilead Sciences, Inc. | 2 | $38 |
| Hologic Sales and Service, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $31 |
| MILLICENT US INC | 1 | $18 |
| Atland Pharmaceuticals, LLC | 1 | $14 |
Products named: AREXVY, APTIMA, Epclusa, INTRAROSA, Cologuard Collection Kit, SHINGRIX, The Cologuard Plus Collection Kit, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE.
Industry payments across AL — which companies pay providers there.
